SYDNEY, March 1, 2026 /PRNewswire/ — Wellkins Capital Limited, a specialist private credit and real estate investment manager, is pleased to announce a new $4.6 million secured mezzanine note issuance by Bella Rosanna Capital Pty Ltd.

The funds raised will support the development of a 27-townhouse residential project located in Rosanna, Victoria. The project is positioned within Melbourne’s established northern residential corridor and is intended for sale upon completion.

The secured mezzanine notes offer a targeted return of 16% per annum (IRR) over a term of up to 24 months. The investment is structured as a secured facility.

Expressions of Interest (EOI) close 9th March 2026.

Important Notice

This announcement is provided for information purposes only and does not constitute an offer, invitation, solicitation or recommendation in relation to the purchase of securities.

The secured mezzanine notes are available to wholesale investors only (as defined under section 761G of the Corporations Act 2001 (Cth)). This material is not intended for, and must not be distributed to, retail investors.

Any investment is subject to risk. The targeted return of 16% per annum (IRR). Prospective investors should obtain and carefully consider all relevant offer documentation and seek independent financial, legal and taxation advice before making any investment decision.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Canary Speech Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Technology Innovation Leadership

Recognized for transforming Intelligent Vocal Biomarker Diagnostics through innovative AI-powered, smartphone-based diagnostic…

Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer

Becomes the 7th International Registrational Clinical Trial for Ivonescimab Clinical Trial Site…

Hangul Comes to Life Across Seoul as Shinsegae Duty Free and Artist Hong In-sook Turn "Annyeong" into Art

SEOUL, South Korea, Oct. 8, 2026 /PRNewswire/ — As global interest in…